← All trials
NCT03307746
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 23, 2017
- Primary completion
- Mar 1, 2019
- Completion date
- Oct 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Moorgreen Hospital, SouthamptonLead sponsor
- University of OxfordCollaborator
- Cancer Research UKCollaborator
- The Christie NHS Foundation TrustCollaborator
- Celldex TherapeuticsCollaborator
- University Hospital Plymouth NHS TrustCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.